Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal)

NICE technology appraisal guidance [TA149] Published date:

NICE is unable to recommend the use in the NHS of carmustine implantsas an adjunct to surgery in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated because no evidence submission was received from the manufacturer or sponsor of the technology.

Get involved